scispace - formally typeset
M

Meifang Han

Researcher at Huazhong University of Science and Technology

Publications -  59
Citations -  8246

Meifang Han is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Hepatitis B virus & HBsAg. The author has an hindex of 17, co-authored 55 publications receiving 6043 citations.

Papers
More filters
Journal ArticleDOI

Clinical and immunological features of severe and moderate coronavirus disease 2019.

TL;DR: The SARS-CoV-2 infection may affect primarily T lymphocytes particularly CD4+T and CD8+ T cells, resulting in decrease in numbers as well as IFN-γ production, which may be of importance due to their correlation with disease severity in COVID-19.
Journal ArticleDOI

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

TL;DR: Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk, including patients with cardiovascular comorbidity.
Journal ArticleDOI

Acute liver failure: mechanisms of immune-mediated liver injury.

TL;DR: This review summarizes current concepts of immune‐mediated liver injury from both clinical studies and animal models and highlights immune responses of ALF from the liver injury perspective, which combines a variety of molecular and cellular mechanisms, particularly, the contribution of cytokines and the innate immune system.
Posted ContentDOI

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019

TL;DR: The SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+T cells, resulting in significant decrease in number as well as IFN-γ production, which may be associated with disease severity in COVID-19.